Modern Rheumatology

Papers
(The H4-Index of Modern Rheumatology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
MEFV E148Q variant is more associated with familial Mediterranean fever when combined with other non-exon 10 MEFV variants in Japanese patients with recurrent fever79
Comparison between the BioPlex 2200 ANA Screen™ and a conventional method with respect to the detection of autoantibodies32
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease31
The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid ar26
Phenotypic landscape of systemic lupus erythematosus: An analysis of the Kyoto Lupus Cohort24
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort24
Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis22
The trends in the prevalence of arthritis and arthralgia and their associations with extra-articular manifestations in patients with Behcet’s disease: A systematic review and meta-analysis22
The dietary acid load is associated with disease severity in psoriatic arthritis20
Expert perspectives on pathological findings in vasculitis20
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review20
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance20
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study19
Consideration of useful patient-reported outcome measures to identify the unmet medical needs of children and adults with autoimmune and autoinflammatory diseases19
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis19
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study18
Characteristics of patients presenting with concomitant carpal tunnel syndrome at the initial diagnosis with rheumatoid arthritis18
Correction to: Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs17
Prevalence of social frailty in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG study)17
Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study17
IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation17
0.23673915863037